Clinical Trial Update: RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating reduced-intensity conditioning allogeneic bone marrow transplant with post-transplant cyclophosphamide for refractory systemic sclero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Systemic Sclerosis | Phase 1 | Status: TERMINATED